1-10 of 10
Verna L Welch, PhD MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patterns of Undertreatment Among Patients with Acute Myeloid Leukemia (AML) Not Receiving Standard Intensive Induction Chemotherapy

Elizabeth Hubscher, Slaven Sikirica, Timothy J. Bell, Andrew Brown, PhD, Verna L Welch, PhD MPH, Alexander Russell-Smith, MSc, Paul G D'Amico, PhDRN,NP
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-137425
Published: 2020
Journal Articles

Treatment Decision Making in AML: Factors of Importance to Clinicians, AML Patients and Their Family

Thomas W. LeBlanc, MDMA,MHS, Roland B. Walter, MD PhD MS, Loriana Hernandez-Aldama, Kate Sully, PhD, Timothy J Bell, MHA, Chloe Johnson, Francois Peloquin, MSc, Adam Gater, Verna L Welch, PhD MPH, Louise O'Hara, Ryan Hohman, Diana Merino, Nigel H. Russell, MD, Neil Horikoshi, Dawn Maze, MDFRCPC,MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3498.
https://doi.org/10.1182/blood-2019-124660
Published: 2019
Journal Articles

Estimating the Relative Treatment Effect and Corresponding Cost-Effectiveness Estimates of Inotuzumab Ozogamicin Vs. Blinatumomab for Adults with Philadelphia Chromosome-Negative (Ph-) Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukaemia (B-ALL) in the United Kingdom (UK)

Simone Critchlow, Miranda Cooper, Ilse van Oostrum, Verna L Welch, PhD MPH, T. Alexander Russell-Smith
Journal: Blood
Blood (2019) 134 (Supplement_1): 3427.
https://doi.org/10.1182/blood-2019-123454
Published: 2019
Journal Articles

Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) and Other High-Grade Myeloid Neoplasms

Anna B. Halpern, MD, Nicholas P Howard, Megan Othus, PhD, Paul C. Hendrie, MD PhD, Nikita Vashi Baclig, MD MPH, Sarah A Buckley, MD, Mary-Elizabeth M. Percival, MD, Pamela S. Becker, MD PhD, Bart L. Scott, MD, Vivian G. Oehler, MD, Terry B. Gernsheimer, MD, Sioban B. Keel, MD, Johnnie Orozco, MD, Ryan D. Cassaday, MD, Andrei R Shustov, MD, Garrett Hartley, Verna L Welch, PhD MPH, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 1317.
https://doi.org/10.1182/blood-2019-124586
Published: 2019
Journal Articles

Comparative Analysis of Patterns of Infectious Complications of Outpatient Vs. Inpatient Care Following Intensive Induction Chemotherapy for Adults with Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasms

Anna B. Halpern, MD, Nicholas P Howard, Megan Othus, PhD, Paul C. Hendrie, MD PhD, Nikita Vashi Baclig, MD MPH, Sarah A Buckley, MD, Mary-Elizabeth M. Percival, MD, Pamela S. Becker, MD PhD, Bart L. Scott, MD, Vivian G. Oehler, MD, Terry B. Gernsheimer, MD, Sioban Keel, MD, Johnnie Orozco, MD, Ryan D. Cassaday, MD, Andrei R Shustov, MD, Garrett Hartley, Verna L Welch, PhD MPH, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 1323.
https://doi.org/10.1182/blood-2019-123605
Published: 2019
Journal Articles

The Impact of Hematopoietic Stem Cell Transplantation on Work and Productivity Loss in Patients with Acute Leukemia: Results from a Rapid Review

Tayler Scory, MSc, Eileen Shaw, MSc, Tara Cowling, MSc, Francois Peloquin, MSc, Verna L Welch, PhD MPH, Majed Charaan, MSc, MBA, Andrew Brown, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5829.
https://doi.org/10.1182/blood-2019-121814
Published: 2019
Journal Articles

Treatment in AML and MDS Patients Who Are Ineligible for Intensive Chemotherapy: Using Social Media Intelligence to Capture What Really Matters to Patients

Alison Booth, MSc, Timothy J Bell, Sonia Halhol, MSc, Shiyu Pan, MSc, Verna L Welch, PhD MPH, CPEHR, CPHIMS, Evie Merinopoulou, MSc, Dimitra Lambrelli, PhD, Andrew Cox, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4826.
https://doi.org/10.1182/blood-2018-99-112827
Published: 2018
Journal Articles

Budget Impact of First-Line Bosutinib for Chronic Phase Chronic Myeloid Leukemia on a US Health Plan

Verna L Welch, PhD MPH, CPEHR, CPHIMS, Peter Quon, MPH, Denise Zou, Jennifer Uyei, PhD MPH, Sherry Wu, MPH, Ying Xiao, Carla M. Mamolo, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5834.
https://doi.org/10.1182/blood-2018-99-110544
Published: 2018
Journal Articles

Using Social Media to Highlight Unmet Needs in Patients with AML and MDS Ineligible for Intensive Chemotherapy: A Patient Centered Perspective

Alison Booth, MSc, Timothy J Bell, Sonia Halhol, MSc, Shiyu Pan, MSc, Verna L Welch, PhD MPH, CPEHR, CPHIMS, Evie Merinopoulou, MSc, Dimitra Lambrelli, PhD, Andrew Cox, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4831.
https://doi.org/10.1182/blood-2018-99-112922
Published: 2018
Journal Articles

A Patient-Centred Approach to Understanding the Trade-Offs Associated with Treatment Decision Making in Hematological Cancers with Short Life Expectancy

Chloe Johnson, Timothy J Bell, Kate Sully, PhD, Verna L Welch, PhD MPH, CPEHR, CPHIMS, Francois Peloquin, BS, Adam Gater
Journal: Blood
Blood (2018) 132 (Supplement 1): 5899.
https://doi.org/10.1182/blood-2018-99-116226
Published: 2018